Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Probiotics: Therapeutic Strategy on the Prevention and Treatment of Inflammatory Diseases: Obesity, Type 2 Diabetes Mellitus and Celiac Disease

Author(s): Elisa dos Santos Pereira*, Chirle de Oliveira Raphaelli, Khadija Bezerra Massaut, Jardel Araújo Ribeiro, Helena Reissig Soares Vitola, Simone Pieniz and Ângela Maria Fiorentini

Volume 20, Issue 9, 2024

Published on: 25 October, 2023

Page: [1112 - 1125] Pages: 14

DOI: 10.2174/0115734013252358231016181809

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Recent evidence demonstrates the fundamental role of the gut microbiota in inflammatory diseases, and several mechanisms of action of probiotics in improvement of inflammatory parameters.

Objectives: The objective of this review was to relate the consumption of probiotic bacteria and its effects on inflammatory diseases, including obesity, type II diabetes and celiac disease.

Methods: A search was carried out in English, between the years 2011 and 2022, for research articles and clinical trials with humans and in vivo studies. Research showed improvement in cardiovascular risk markers, and improvement in insulin sensitivity, lipid profile and plasma atherogenic index, in obesity with the use of probiotics. In type II diabetes, decreased levels of fasting glucose, glycated hemoglobin, insulin and glycemic index, and increased levels of peptide 1, superoxide dismutase and glutathione peroxidase were observed.

Results: In addition to cellular protection of the islets of Langerhans and positive alteration of TNF- α and IL-1β markers. Improvement in the condition of patients with celiac disease was observed, since the neutralization of the imbalance in serotonin levels was observed, reducing the expression of genes of interest and also, a decrease in cytokines.

Conclusion: Therefore, the use of probiotics should be encouraged.

Keywords: Gut microbiota, inflammatory processes, gut dysbiosis, probiotic supplementation, lipid profile, islets of langerhans.

« Previous Next »
Graphical Abstract

[1]
Widgerow AD. Cellular resolution of inflammation-catabasis. Wound Repair Regen 2012; 20(1): 2-7.
[http://dx.doi.org/10.1111/j.1524-475X.2011.00754.x] [PMID: 22276585]
[2]
Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8(Suppl 2): S3.
[http://dx.doi.org/10.1186/ar1917] [PMID: 16899107]
[3]
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res 2016; 118(11): 1723-35.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306825] [PMID: 27230638]
[4]
King JA, Jeong J, Underwood F, Quan J, Panaccione N, Windsor JW, et al. Incidence of celiac disease is increasing over time: A systematic review and meta-analysis. Am J Gastroenterol 2020; 115(4): 507-25.
[http://dx.doi.org/10.14309/ajg.0000000000000523]
[5]
Green PHR, Cellier C. Celiac disease. N Engl J Med 2007; 357(17): 1731-43.
[http://dx.doi.org/10.1056/NEJMra071600] [PMID: 17960014]
[6]
Galipeau HJ, McCarville JL, Huebener S, et al. Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol 2015; 185(11): 2969-82.
[http://dx.doi.org/10.1016/j.ajpath.2015.07.018] [PMID: 26456581]
[7]
Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution pharmacology: Opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 2015; 36(11): 737-55.
[http://dx.doi.org/10.1016/j.tips.2015.07.007] [PMID: 26478210]
[8]
FAO/WHO. Working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada 2002; p. 30.
[9]
Hill C, Guarner F, Reid G, et al. The International scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-14.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[10]
Liong MT, Lee BH, Choi SB, Lew LC, Lau ASY, Daliri BME. Cholesterol-lowering effects of probiotics and prebiotics. Int J Mol Sci 2015; 11(6): 2499-522.
[http://dx.doi.org/10.21775/9781910190098.29]
[11]
Camargo Prado F, De Dea Lindner J, Inaba J, Thomaz-Soccol V, Kaur Brar S, Soccol CR. Development and evaluation of a fermented coconut water beverage with potential health benefits. J Funct Foods 2015; 12: 489-97.
[http://dx.doi.org/10.1016/j.jff.2014.12.020]
[12]
Cani PD, Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 2015; 32: 21-7.
[http://dx.doi.org/10.1016/j.copbio.2014.10.006] [PMID: 25448228]
[13]
Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics: A review. J Food Sci Technol 2015; 52(12): 7577-87.
[http://dx.doi.org/10.1007/s13197-015-1921-1] [PMID: 26604335]
[14]
de Almeida NEC, Esteves FG, dos Santos-Pinto JRA, et al. Digestion of intact gluten proteins by Bifidobacterium species: Reduction of cytotoxicity and proinflammatory responses. J Agric Food Chem 2020; 68(15): 4485-92.
[http://dx.doi.org/10.1021/acs.jafc.0c01421] [PMID: 32195585]
[15]
Islam SU. Clinical uses of probiotics. Medicine 2016; 95(5): e2658.
[http://dx.doi.org/10.1097/MD.0000000000002658] [PMID: 26844491]
[16]
Parker RB. The other half of the antibiotics story. Anim Nutr Health 1974; 29: 4-8.
[17]
Korbekandi H, Mortazavian AM, Iravani S. Technology and stability of probiotic in fermented milks containing probiotics and prebiotics. Probiotic and Prebiotic Foods: Technology, Stability and Benefits to the Human Health. USA: Nova Science Publishers, Inc. 2011.
[18]
Zendeboodi F, Khorshidian N, Mortazavian AM, da Cruz AG. Probiotic: Conceptualization from a new approach. Curr Opin Food Sci 2020; 32: 103-23.
[http://dx.doi.org/10.1016/j.cofs.2020.03.009]
[19]
Sarkar S. Whether viable and dead probiotic are equally efficacious? Nutr Food Sci 2018; 48(2): 285-300.
[http://dx.doi.org/10.1108/NFS-07-2017-0151]
[20]
Pais P, Almeida V, Yılmaz M, Teixeira MC. Saccharomyces boulardii: what makes it tick as successful probiotic? J Fungi 2020; 6(2): 78.
[http://dx.doi.org/10.3390/jof6020078] [PMID: 32512834]
[21]
Surendran Nair M, Amalaradjou MA, Venkitanarayanan K. Antivirulence properties of probiotics in combating microbial pathogenesis. Adv Appl Microbiol 2017; 98: 1-29.
[http://dx.doi.org/10.1016/bs.aambs.2016.12.001] [PMID: 28189153]
[22]
Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006; 100(6): 1171-85.
[http://dx.doi.org/10.1111/j.1365-2672.2006.02963.x] [PMID: 16696665]
[23]
Mayer EA. Gut feelings: The emerging biology of gut–brain communication. Nat Rev Neurosci 2011; 12(8): 453-66.
[http://dx.doi.org/10.1038/nrn3071] [PMID: 21750565]
[24]
Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 2013; 109(S2) (Suppl. 2): S35-50.
[http://dx.doi.org/10.1017/S0007114512004011] [PMID: 23360880]
[25]
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr 2019; 10 (Suppl. 1): S49-66.
[http://dx.doi.org/10.1093/advances/nmy063] [PMID: 30721959]
[26]
Guarner F, Sanders ME, Eliakim R, et al. WGO Practice Guideline. Probiotics and Prebiotics. 2017.
[27]
Costa GM, Paula MM, Barão CE, et al. Yoghurt added with Lactobacillus casei and sweetened with natural sweeteners and/or prebiotics: Implications on quality parameters and probiotic survival. Int Dairy J 2019; 97: 139-48.
[http://dx.doi.org/10.1016/j.idairyj.2019.05.007]
[28]
Papadopoulou OS, Argyri AA, Varzakis EE, Tassou CC, Chorianopoulos NG. Greek functional Feta cheese: Enhancing quality and safety using a Lactobacillus plantarum strain with probiotic potential. Food Microbiol 2018; 74: 21-33.
[http://dx.doi.org/10.1016/j.fm.2018.02.005] [PMID: 29706334]
[29]
Afrc RF. Probiotics in man and animals. J Appl Bacteriol 1989; 66(5): 365-78.
[http://dx.doi.org/10.1111/j.1365-2672.1989.tb05105.x] [PMID: 2666378]
[30]
Ambalam P, Raman M, Purama RK, Doble M. Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol 2016; 30(1): 119-31.
[http://dx.doi.org/10.1016/j.bpg.2016.02.009] [PMID: 27048903]
[31]
Orlando A, Clemente C, D’Attoma B, Russo F. Effects of Lactobacillus rhamnosus GG on the serotonergic pathway in a gliadin-induced enteropathy animal model. J Funct Foods 2020; 72: 104077.
[http://dx.doi.org/10.1016/j.jff.2020.104077]
[32]
Pontes KSS, Guedes MR, Cunha MR, et al. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2021; 40(8): 4915-31.
[http://dx.doi.org/10.1016/j.clnu.2021.06.023] [PMID: 34358838]
[33]
Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6(11): e280.
[http://dx.doi.org/10.1371/journal.pbio.0060280] [PMID: 19018661]
[34]
Martín R, Miquel S, Ulmer J, Langella P, Bermúdez-Humarán LG. Gut ecosystem: How microbes help us. Benef Microbes 2014; 5(3): 219-33.
[http://dx.doi.org/10.3920/BM2013.0057] [PMID: 24583612]
[35]
Morgun A, Dzutsev A, Dong X, Greer RL, Sexton DJ, Ravel J, et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut Microbiotat 2015; 64(11): 308820.
[http://dx.doi.org/10.1136/gutjnl-2014-308820]
[36]
Kleessen B, Bezirtzoglou E, Matto J. Culture-based knowledge on biodiversity, development and stability of human gastrointestinal microflora. Microb Ecol Health Dis 2000; 12(2): 53-63.
[http://dx.doi.org/10.1080/089106000750060305]
[37]
Schmeisser C, Steele H, Streit WR. Metagenomics, biotechnology with non-culturable microbes. Appl Microbiol Biotechnol 2007; 75(5): 955-62.
[http://dx.doi.org/10.1007/s00253-007-0945-5] [PMID: 17396253]
[38]
Liu Z, Liu W, Ran C, Hu J, Zhou Z. Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis. Sci Rep 2016; 6(1): 23214.
[http://dx.doi.org/10.1038/srep23214] [PMID: 26983596]
[39]
Zhang Q, Pan Y, Zeng B, et al. Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells. Cell Res 2019; 29(7): 516-32.
[http://dx.doi.org/10.1038/s41422-019-0190-3] [PMID: 31201384]
[40]
Okunogbe A, Nugent R, Spencer G, Ralston J, Wilding J. Economic impacts of overweight and obesity: Current and future estimates for eight countries. BMJ Glob Health 2021; 6(10): e006351.
[http://dx.doi.org/10.1136/bmjgh-2021-006351] [PMID: 34737167]
[41]
Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012; 3(1): 4-14.
[http://dx.doi.org/10.4161/gmic.19320] [PMID: 22356853]
[42]
Schütz F, Figueiredo-Braga M, Barata P, Cruz-Martins N. Obesity and gut microbiome: Review of potential role of probiotics. Porto Biomed J 2021; 6(1): e111.
[http://dx.doi.org/10.1097/j.pbj.0000000000000111] [PMID: 33490703]
[43]
Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the treatment of overweight and obesity in humans - a review of clinical trials. Microorganisms 2020; 8(8): 1148.
[http://dx.doi.org/10.3390/microorganisms8081148] [PMID: 32751306]
[44]
Nagpal R, Newman TM, Wang S, Jain S, Lovato JF, Yadav H. Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet. J Diabetes Res 2018; 2018: 1-9.
[http://dx.doi.org/10.1155/2018/3462092] [PMID: 30250849]
[45]
Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: Role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr 2020; 123(10): 1127-37.
[http://dx.doi.org/10.1017/S0007114520000380] [PMID: 32008579]
[46]
Yoo SR, Kim YJ, Park DY, et al. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013; 21(12): 2571-8.
[http://dx.doi.org/10.1002/oby.20428] [PMID: 23512789]
[47]
Gomes AC, Hoffmann C, Mota JF. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr 2020; 59(4): 1751-62.
[http://dx.doi.org/10.1007/s00394-019-02034-0] [PMID: 31250099]
[48]
Wang Y, Wu Y, Wang B, et al. Bacillus amyloliquefaciens SC06 protects mice against high-fat diet-induced obesity and liver injury via regulating host metabolism and gut microbiota. Front Microbiol 2019; 10: 1161.
[http://dx.doi.org/10.3389/fmicb.2019.01161] [PMID: 31191487]
[49]
Homayoni R. A, Vaghef Mehrabany E, Alipoor B, Vaghef Mehrabany L. The comparison of food and supplement as probiotic delivery vehicles. Crit Rev Food Sci Nutr 2016; 56(6): 896-909.
[http://dx.doi.org/10.1080/10408398.2012.733894] [PMID: 25117939]
[50]
Miyoshi M, Ogawa A, Higurashi S, Kadooka Y. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 2014; 53(2): 599-606.
[http://dx.doi.org/10.1007/s00394-013-0568-9] [PMID: 23917447]
[51]
Song EJ, Han K, Lim TJ, et al. Effect of probiotics on obesity-related markers per enterotype: A double-blind, placebo-controlled, randomized clinical trial. EPMA J 2020; 11(1): 31-51.
[http://dx.doi.org/10.1007/s13167-020-00198-y] [PMID: 32140184]
[52]
Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial. Mediators Inflamm 2014; 2014: 1-8.
[http://dx.doi.org/10.1155/2014/348959] [PMID: 24795503]
[53]
Goyal R, Jialal I. Diabetes mellitus type 2. StatPearls Publishing: Treasure Island (FL) 2018.
[54]
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-81.
[http://dx.doi.org/10.1016/j.diabres.2018.02.023] [PMID: 29496507]
[55]
Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med 2016; 375(24): 2369-79.
[http://dx.doi.org/10.1056/NEJMra1600266] [PMID: 27974040]
[56]
Tang WHW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res 2017; 120(7): 1183-96.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.309715] [PMID: 28360349]
[57]
Al-Jameel SS. Association of diabetes and microbiota: An update. Saudi J Biol Sci 2021; 28(8): 4446-54.
[http://dx.doi.org/10.1016/j.sjbs.2021.04.041] [PMID: 34354429]
[58]
Kasińska MA, Drzewoski J. Effectiveness of probiotics in type 2 diabetes: A meta-analysis. Pol Arch Intern 2015; 125(11): 803-13.
[http://dx.doi.org/10.20452/pamw.3156] [PMID: 26431318]
[59]
Duan FF, Liu JH, March JC. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes 2015; 64(5): 1794-803.
[http://dx.doi.org/10.2337/db14-0635] [PMID: 25626737]
[60]
Stenman LK, Waget A, Garret C, et al. Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice. Diabetol Metab Syndr 2015; 7(1): 75.
[http://dx.doi.org/10.1186/s13098-015-0075-7] [PMID: 26366205]
[61]
Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011; 34(2): 392-7.
[http://dx.doi.org/10.2337/dc10-1676] [PMID: 21270197]
[62]
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012; 28(5): 539-43.
[http://dx.doi.org/10.1016/j.nut.2011.08.013] [PMID: 22129852]
[63]
Randhawa MK, Bhatia A, Balgir P. Effect of supplementation of probiotic and their DNA alone or in combination with glyburide on hyperglycemic swiss albino mice. Int J Pharm Chem Anal 2015; 2(2): 71-6.
[64]
Yan F, Li N, Yue Y, et al. Screening for potential novel probiotics with dipeptidyl peptidase IV-inhibiting activity for type 2 diabetes attenuation in vitro and in vivo. Front Microbiol 2020; 10: 2855.
[http://dx.doi.org/10.3389/fmicb.2019.02855] [PMID: 31998245]
[65]
Zeng Z, Yuan Q, Yu R, Zhang J, Ma H, Chen S. Ameliorative effects of probiotic Lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. Mol Nutr Food Res 2019; 63(22): 1900457.
[http://dx.doi.org/10.1002/mnfr.201900457] [PMID: 31433912]
[66]
Tonucci LB, Olbrich dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr 2017; 36(1): 85-92.
[http://dx.doi.org/10.1016/j.clnu.2015.11.011] [PMID: 26732026]
[67]
Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran J Med Sci 2013; 38(1): 38-43.
[PMID: 23645956]
[68]
Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Kyriienko D, Komissarenko I. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial. Diabetes Metab Syndr 2018; 12(5): 617-24.
[http://dx.doi.org/10.1016/j.dsx.2018.04.015] [PMID: 29661605]
[69]
Ostadrahimi A, Taghizadeh A, Mobasseri M, et al. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Iran J Public Health 2015; 44(2): 228-37.
[PMID: 25905057]
[70]
Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013; 62(1): 43-52.
[http://dx.doi.org/10.1136/gutjnl-2011-301346] [PMID: 22345659]
[71]
Bai JC, Ciacci C. World Gastroenterology Organisation Global Guidelines: Celiac Disease February 2017. J Clin Gastroenterol 2016; 51(9): 755-68.
[72]
Sbai W, Bourgain G, Luciano L, et al. Celiac crisis in a multi-trauma adult patient. Clin Res Hepatol Gastroenterol 2016; 40(3): e31-2.
[http://dx.doi.org/10.1016/j.clinre.2015.10.003] [PMID: 26547137]
[73]
Santonicola A, Iovino P, Cappello C, Capone P, Andreozzi P, Ciacci C. From menarche to menopause. Menopause 2011; 18(10): 1125-30.
[http://dx.doi.org/10.1097/gme.0b013e3182188421] [PMID: 21646922]
[74]
Al-Toma A, Volta U, Auricchio R, et al. European society for the study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J 2019; 7(5): 583-613.
[http://dx.doi.org/10.1177/2050640619844125] [PMID: 31210940]
[75]
Lindfors K, Koskinen O, Kaukinen K. An update on the diagnostics of celiac disease. Int Rev Immunol 2011; 30(4): 185-96.
[http://dx.doi.org/10.3109/08830185.2011.595854] [PMID: 21787224]
[76]
Mårild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF. Pregnancy outcome and risk of celiac disease in offspring: A nationwide case-control study. Gastroenterology 2012; 142(1): 39-45.e3.
[http://dx.doi.org/10.1053/j.gastro.2011.09.047] [PMID: 21995948]
[77]
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486(7402): 222-7.
[http://dx.doi.org/10.1038/nature11053] [PMID: 22699611]
[78]
Sanz Y, Palma GD, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 2011; 30(4): 207-18.
[http://dx.doi.org/10.3109/08830185.2011.599084] [PMID: 21787226]
[79]
Ivarsson A, Hernell O, Stenlund H, Persson LÅ. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75(5): 914-21.
[http://dx.doi.org/10.1093/ajcn/75.5.914] [PMID: 11976167]
[80]
Sandberg-Bennich S, Dahlquist G, Källén B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr 2002; 91(1): 30-3.
[http://dx.doi.org/10.1111/j.1651-2227.2002.tb01635.x] [PMID: 11883814]
[81]
Woo V, Alenghat T. Host–microbiota interactions: Epigenomic regulation. Curr Opin Immunol 2017; 44: 52-60.
[http://dx.doi.org/10.1016/j.coi.2016.12.001] [PMID: 28103497]
[82]
Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013; 14(7): 676-84.
[http://dx.doi.org/10.1038/ni.2640] [PMID: 23778795]
[83]
Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019; 7(1): 14.
[http://dx.doi.org/10.3390/microorganisms7010014] [PMID: 30634578]
[84]
Wacklin P, Kaukinen K, Tuovinen E, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013; 19(5): 934-41.
[http://dx.doi.org/10.1097/MIB.0b013e31828029a9] [PMID: 23478804]
[85]
Cheng J, Kalliomäki M, Heilig HGHJ, et al. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol 2013; 13(1): 113.
[http://dx.doi.org/10.1186/1471-230X-13-113] [PMID: 23844808]
[86]
Nistal E, Caminero A, Herrán AR, et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: Effect of age, gluten diet, and disease. Inflamm Bowel Dis 2012; 18(4): 649-56.
[http://dx.doi.org/10.1002/ibd.21830] [PMID: 21826768]
[87]
Laparra JM, Olivares M, Gallina O, Sanz Y. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 2012; 7(2): e30744.
[http://dx.doi.org/10.1371/journal.pone.0030744] [PMID: 22348021]
[88]
D’Arienzo R, Stefanile R, Maurano F, et al. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand J Immunol 2011; 74(4): 335-41.
[http://dx.doi.org/10.1111/j.1365-3083.2011.02582.x] [PMID: 21615450]
[89]
Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol 2013; 47(2): 139-47.
[http://dx.doi.org/10.1097/MCG.0b013e31827759ac] [PMID: 23314670]
[90]
Pinto-Sánchez MI, Smecuol EC, Temprano MP, et al. Bifidobacterium infantis NLS super strain reduces the expression of α-defensin-5, a marker of innate immunity, in the mucosa of active celiac disease patients. J Clin Gastroenterol 2017; 51(9): 814-7.
[http://dx.doi.org/10.1097/MCG.0000000000000687] [PMID: 27636409]
[91]
Klemenak M, Dolinšek J, Langerholc T, Di Gioia D, Mičetić-Turk D. Administration of Bifidobacterium breve decreases the production of TNF-α in children with celiac disease. Dig Dis Sci 2015; 60(11): 3386-92.
[http://dx.doi.org/10.1007/s10620-015-3769-7] [PMID: 26134988]
[92]
Quagliariello A, Aloisio I, Bozzi Cionci N, et al. Effect of Bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: A pilot study. Nutrients 2016; 8(10): 660.
[http://dx.doi.org/10.3390/nu8100660] [PMID: 27782071]
[93]
Primec M, Klemenak M, Di Gioia D, et al. Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clin Nutr 2019; 38(3): 1373-81.
[http://dx.doi.org/10.1016/j.clnu.2018.06.931] [PMID: 29960810]
[94]
Olivares M, Castillejo G, Varea V, Sanz Y. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br J Nutr 2014; 112(1): 30-40.
[http://dx.doi.org/10.1017/S0007114514000609] [PMID: 24774670]
[95]
Harnett J, Myers SP, Rolfe M. Probiotics and the microbiome in celiac disease: A randomised controlled trial. Evid Based Complement Alternat Med 2016; 2016: 1-16.
[http://dx.doi.org/10.1155/2016/9048574] [PMID: 27525027]
[96]
Francavilla R, Piccolo M, Francavilla A, et al. Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent IBS-type symptoms. J Clin Gastroenterol 2019; 53(3): e117-25.
[http://dx.doi.org/10.1097/MCG.0000000000001023] [PMID: 29688915]
[97]
Savilahti EM, Ilonen J, Kukkonen AK, Savilahti E, Kuitunen M. Celiac disease by the age of 13 years is not associated with probiotics administration in infancy. J Pediatr Gastroenterol Nutr 2018; 66(6): 937-40.
[http://dx.doi.org/10.1097/MPG.0000000000001846] [PMID: 29210921]
[98]
Håkansson A, Andrén Aronsson A, Brundin C, Oscarsson E, Molin G, Agardh D. Effects of Lactobacillus plantarum and Lactobacillus paracasei on the peripheral immune response in children with celiac disease autoimmunity: A randomized, double-blind, placebo-controlled clinical trial. Nutrients 1925; 11(8): 1925.
[http://dx.doi.org/10.3390/nu11081925]
[99]
Caminero A, Galipeau HJ, McCarville JL, et al. Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology 2016; 151(4): 670-83.
[http://dx.doi.org/10.1053/j.gastro.2016.06.041] [PMID: 27373514]
[100]
Caminero A, Herrán AR, Nistal E, et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: Isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol 2014; 88(2): 309-19.
[http://dx.doi.org/10.1111/1574-6941.12295] [PMID: 24499426]
[101]
Olivares M, Laparra M, Sanz Y. Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal epithelial cell proteome. J Agric Food Chem 2011; 59(14): 7666-71.
[http://dx.doi.org/10.1021/jf201212m] [PMID: 21651295]
[102]
Marinelli L, Tenore GC, Novellino E. Probiotic species in the modulation of the anticancer immune response. Semin Cancer Biol 2017; 46: 182-90.
[http://dx.doi.org/10.1016/j.semcancer.2017.08.007] [PMID: 28844794]
[103]
Xu F, Li Q, Wang S, et al. Lactobacillus casei JY300-8 generated by 12C6+ beams mutagenesis inhibits tumor progression by modulating the gut microbiota in mice. J Funct Foods 2021; 87: 104779.
[http://dx.doi.org/10.1016/j.jff.2021.104779]
[104]
Lin WY, Lin JH, Kuo YW, Chiang PFR, Ho HH. Probiotics and their metabolites reduce oxidative stress in middle-aged mice. Curr Microbiol 2022; 79(4): 104.
[http://dx.doi.org/10.1007/s00284-022-02783-y] [PMID: 35157139]
[105]
Han SK, Shin YJ, Lee DY, et al. Lactobacillus rhamnosus HDB1258 modulates gut microbiota-mediated immune response in mice with or without lipopolysaccharide-induced systemic inflammation. BMC Microbiol 2021; 21(1): 146.
[http://dx.doi.org/10.1186/s12866-021-02192-4] [PMID: 33985438]
[106]
Karaffová V, Mudroňová D, Mad’ar M, et al. Differences in immune response and biochemical parameters of mice fed by kefir milk and lacticaseibacillus paracasei isolated from the kefir grains. Microorganisms 2021; 9(4): 831.
[http://dx.doi.org/10.3390/microorganisms9040831] [PMID: 33919782]
[107]
Toukam LL, Tatsinkou Fossi B, Taiwe GS, et al. In vivo antimalarial activity of a probiotic bacterium Lactobacillus sakei isolated from traditionally fermented milk in BALB/c mice infected with Plasmodium berghei ANKA. J Ethnopharmacol 2021; 280: 114448.
[http://dx.doi.org/10.1016/j.jep.2021.114448] [PMID: 34303805]
[108]
Kang Y, Kang X, Yang H, et al. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol Res 2022; 175: 106020.
[http://dx.doi.org/10.1016/j.phrs.2021.106020] [PMID: 34896249]

Rights & Permissions Print Cite
Article Metrics
13
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy